Rapid selection of antigen-specific T lymphocytes by retroviral transduction

Blood

Volumn 96, Issue 1, 2000, Pages 109-117

  Koehne, Guenther ^b   Gallardo, Humilidad F ^b   Sadelain, Michel ^b   O'Reilly, Richard J ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS VECTOR;

ANTIGEN SPECIFICITY; ARTICLE; BINDING AFFINITY; CELL SELECTION; CONTROLLED STUDY; EPSTEIN BARR VIRUS; GENE TRANSFER; HUMAN; HUMAN CELL; LYMPHOMA; PRIORITY JOURNAL; RETROVIRUS; T LYMPHOCYTE ACTIVATION;

EID: 0034234757     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v96.1.109.013k44_109_117     Document Type: Article

References (31)

1. Bhatia S, Ramsay NK, Steinbuch M. et al. Malignant neoplasms following bone marrow transplantation. Blood. 1996;87:3633-3639.
2. Witherspoon RP, Fisher LD, Schoch G, et al. Secondary cancers after bone marrow transplantation for leukemia or aplastic anemia. N Engl J Med. 1989;321:784-789.
3. O'Reilly RJ, Small TN, Papadopoulos E, Lucas K, Lacerda J, Koulova L. Adoptive immunotherapy for EBV-associated lymphoproliferative disorders complicating marrow allografts. Springer Semin Immunopathol. 1998;20:455-491.
4. Curtis RE, Travis LB, Rowlings PA, et al. Risk of lymphoproliferative disorders following bone marrow transplantation: a multi-institutional study. Blood. 1999;94:2208-2216.
5. Papadopoulos EB, Ladanyi M, Emanuel D, et al. Infusions of donor leukocytes as treatment of Epstein-Barr virus associated lymphoproliferative disorders complicating allogeneic marrow transplantation. N Engl J Med. 1994;330:1185-1191.
6. Rooney CM, Smith CA, Ng, CY, et al. Use of gene-modified virus-specific T-lymphocytes to control Epstein-Barr-virus-related lymphoproliferation. Lancet. 1995;345:9-13.
7. Porter D. Unrelated donor leukocyte infusions (U-DLI) to treat relapse or EBV-lymphoproliferative disease (EBV-LPD) after unrelated bone marrow transplantation (BMT) [abstract]. Blood. 1994;90:590a.
8. Heslop HE, Brenner MK, Rooney CM. Donor T cells to treat EBV-associated lymphoma. N Engl J Med. 1994;331:679-680.
9. Bonini C, Ferrari G, Verzeletti S, et al. HSV-TK gene transfer into donor lymphocytes for control of allogeneic gratt-versus-leukemia. Science. 1997;276:1719-1724.
10. Smith CA, Ng CY, Heslop HE, et al. Production of genetically modified Epstein-Barr virus-specific cytotoxic T cells for adoptive transfer to patients at high risk of EBV-associated lymphoproliferative disease. J Hematother. 1995;4:73-79.
11. Riddell SR, Watanabe KS, Goodrich JM, Li CR, Agha ME, Greenberg PD. Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones. Science. 1992;257: 238-241.
12. Walter EA, Greenberg PD, Gilbert MJ, et al. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N Engl J Med. 1995;333:1038-1044.
13. Sadelain M, Mulligan RC. Efficient retroviral-medialed gene transfer into murine primary lymphocytes [abstract]. In: Gergely J, ed. Progress in Immunology VIII. Berlin: Springer-Verlag: 1993:34.
14. Tiberghien P, Reynolds CW, Keller J, et al. Ganciclovir treatment of herpes simplex thymidine kinase-transduced primary T lymphocytes: an approach for specific in vivo donor T cell depletion after bone marrow transplantation. Blood. 1994; 84:1333-1340.
15. Miller DG, Adam MA, Miller AD. Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol Cell Biol. 1990;10:4239-4292.
16. Roe TY, Reynolds TC, Yu G, Brown PO. Integration of murine leukemia virus DNA depends on mitosis. EMBO J. 1993;12:2099-2108.
17. Gallardo HF, Tan C, Sadelain M. The internal ribosomal entry site of the encephalomyocarditis virus enables reliable coexpression of two transgenes in human primary T lymphocytes. Gene Ther. 1997;4:1115-1119.
18. Pollok KE, Hanenberg H, Noblitt TW, et al. High-efficiency gene transfer into normal and adenosine deaminase-deficient T lymphocytes is mediated by transduction on recombinant fibronectin fragments. J Virol. 1998;72:4882-4892.
19. Bourgault I, Gomez A, Gomard E, Levy JP. Limiting-dilution analysis of the HLA restriction of anti-Epstein-Barr virus-specific cytolytic T lymphocytes. Clin Exp Immunol. 1991;84:501-507.
20. Langhorne J, Lindhal KF. Limiting dilution analysis of precursors of cytotoxic T lymphocytes. Immunol Methods. 1981;2:221.
21. Lucas KG, Small TN, Heller G, Dupont B, O'Reilly RJ. The development of cellular immunity to Epstein-Barr virus following allogeneic bone marrow transplantation. Blood. 1996;87:2594-2603.
22. Taswell C. Limiting dilution assays for the determination of immunocompetent cell frequencies. III. Validity tests for the single-hit Poisson model. J Immunol Methods. 1984;72:29-40.
23. Kaminski E, Hows J, Man S, et al. Prediction of graft-versus-host disease by frequency analysis of cytotoxic T cells after unrelated donor bone marrow transplantation. Transplantation. 1989; 48:608.
24. Contassot E, Murphy W, Angonin R, et al. In vivo alloreactive potential of ex vivo-expanded primary T lymphocytes. Transplantation. 1998;65:1365-1370.
25. Rooney CM, Smith CA, Ng CY, et al. Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients. Blood. 1998;92: 1549-1555.
26. Murali-Krishna K, Altman JD, Suresh M, et al. Counting antigen-specific CD8+ T cells: a reevaluation of bystander activation during viral infection. Immunity. 1998;8:177.
27. Tan LC, Gudgeon N, Annels NE, et al. A re-evaluation of the frequency of CD8+ T cells specific for EBV in healthy virus carriers. J Immunol. 1999; 162:1627-1835.
28. Heslop HE, Ng CY, Li C, et al. Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes. Nat Med. 1996;2:551-555.
29. Toes REM, Schoenberger SP, van der Voort EIH, Offringa R, Melief CJM. CD4 T cells and their role in antitumor immune responses. J Exp Med. 1999;189:753-756.
30. Steven N, Leese AM, Annels NE, Lee SP, Rickinson AB. Epitope focusing in the primary cytotoxic T cells response to Epstein-Barr virus and its relationship to T cell memory. J Exp Med. 1996;184: 1801.
31. Gavioli R, Kurilla MG, de Campos-Lima PO, et al. Multiple HLA A11-restricted cytotoxic T lymphocyte epitopes of different immunogenicities in the Epstein-Barr virus-encoded nuclear antigen. J Virol. 1993;67:1572.